Impact of FDG PET in optimizing patient selection for cytoreductive surgery in recurrent ovarian cancer

European Journal of Nuclear Medicine and Molecular Imaging
Yasuhiko EbinaNoriaki Sakuragi


To investigate the impact of PET and PET/CT scanning on decision-making in management planning and to identify the optimal setting for selecting candidates for surgery in suspicious recurrent ovarian cancer. A retrospective chart review was performed in patients with possible recurrent ovarian cancer after primary optimal cytoreduction and taxane/carboplatin chemotherapy who had undergone FDG PET or FDG PET/CT scans from July 2002 to August 2008 to help make treatment decisions. The analysis included 44 patients who had undergone a total of 89 PET scans. The positive PET scans were classified as follows. (1) localized (one or two localized sites of FDG uptake), (2) multiple (three or more sites of FDG uptake), (3) diffuse (extensive low-grade activity outlining serosal and peritoneal surfaces). Of the 89 PET scans, 52 (58.4%) led to a change in management plan. The total number of patients in whom cytoreductive surgery was selected as the treatment of choice increased from 12 to 35. Miliary disseminated disease, which was not detected by PET scan, was found in 22.2% of those receiving surgery. Miliary disseminated disease was detected in 6 of the 12 patients with recurrent disease whose treatment-free interval (TFI) was <12 mon...Continue Reading


Apr 1, 1991·American Journal of Clinical Oncology·C HisingN Einhorn
Oct 4, 1989·Journal of the National Cancer Institute·C MangioniW Torri
Apr 1, 1996·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G J RustinH E Lambert
Apr 22, 2006·Gynecologic Oncology·Bryony SimcockRodney J Hicks
Dec 21, 2006·European Journal of Nuclear Medicine and Molecular Imaging·G MangiliF Fazio
Feb 24, 2007·European Journal of Nuclear Medicine and Molecular Imaging·María José García-VellosoJosé Angel Richter
Apr 4, 2007·Abdominal Imaging·Sunit SebastianPeter F Hahn
Oct 22, 2008·Gynecologic Oncology·Robert E BristowDennis S Chi
Feb 16, 2010·Gynecologic Oncology·Edward J TannerRobert E Bristow
Oct 5, 2010·Lancet·Gordon J S RustinUNKNOWN EORTC 55955 investigators
Jan 18, 2011·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Azahara PalomarStefano Fanti
Mar 19, 2013·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Zhao LimeiLiang Zhiqing

❮ Previous
Next ❯


May 28, 2014·Best Practice & Research. Clinical Obstetrics & Gynaecology·Antonia Carla TestaVittoria Rufini
Apr 20, 2014·Japanese Journal of Radiology·Kazuhiro KitajimaKazuro Sugimura
Oct 1, 2014·Cancers·Andrea GallaminiAnna Borra
Jun 9, 2015·Seminars in Nuclear Medicine·Swapnil BagadeFarrokh Dehdashti
Sep 20, 2016·Obstetrical & Gynecological Survey·Jorge Daniel Oldan, Parth S Patel
Feb 10, 2017·European Journal of Nuclear Medicine and Molecular Imaging·Benjapa KhiewvanAbass Alavi
May 22, 2020·Journal of Ovarian Research·Tung Tung TsoiElaine Y P Lee
Jun 20, 2020·AJR. American Journal of Roentgenology·Elaine Y P LeePek-Lan Khong
Sep 9, 2017·The Journal of Obstetrics and Gynaecology Research·Hideaki Tsuyoshi, Yoshio Yoshida
Oct 22, 2019·Seminars in Nuclear Medicine·Jukka KemppainenMarko Seppänen

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Enora LaasElisabeth Chéreau
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Ate G J van der ZeePaolo Zola
© 2021 Meta ULC. All rights reserved